Another factor that the IFN signaling axis may impact, potentially related to tumor progression or regression, is the expression of MHC class I. The epigenetic silencing of MHC class I genes is significant in prostate cancer [126,127]. This evidence concerns the gene IFNA1 and neoplasm.